Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Q&A: Prem S. Subramanian, MD, PhD, on neuro-ophthalmic insights at EyeCon 2025 | Ophthalmology Times
Prem S. Subramanian, MD, PhD, emphasized the importance of pattern recognition in distinguishing ocular from neurologic causes of visual symptoms during EyeCon 2025. (Image credit: AdobeStock/ryandi) “Pattern recognition is key,” emphasized Prem S. Subramanian, MD, PhD, as he discussed the…
Q&A: Marion Munk discusses the phase 2a BETTER study | Ophthalmology Times
Photo of Marion Munk at EURETINA 2025 In her conversation with the Eye Care Network, Marion Munk, MD, PhD, details a promising phase 2a clinical study of ISTH0036, an oligonucleotide antisense drug targeting TGF-β2. Developed to address fibrosis in neovascular…
EyeCon 2025: Adopting an interventional glaucoma mindset with Oluwatosin U. Smith, MD | Ophthalmology Times
At this year’s EyeCon meeting, Oluwatosin U. Smith, MD, of the Glaucoma Associates of Texas, reflected on her dual role—both as an educator and a leader in its development—while delivering a focused presentation on the current state of glaucoma care.…
MacuMira launches first Health Canada-approved device for AMD treatment | Ophthalmology Times
(Image Credit: AdobeStock) Canadian medical device company MacuMira Medical Devices recently introduced the first Health Canada-approved treatment to improve visual function for patients with dry age-related macular degeneration (AMD).1 This new technology, the MacuMira system, is a non-invasive treatment now…
EyeCon 2025 celebrates Visionary in Eye Care Resident Award winners | Ophthalmology Times
The recipients of this year’s Visionary in Eye Care Resident Recognition Awards were revealed at the Ophthalmology Times and Optometry Times EyeCon® 2025 conference, held September 26 and 27 at the Margaritaville Hollywood Beach Resort, in Hollywood, Florida. The program…
Q&A: Anat Loewenstein on the Ramin Tadayoni Award | Ophthalmology Times
Photo of Anat Loewenstein, MD, who served as the 2025 EURETINA president The Ramin Tadayoni Award is an initiative by the EURETINA board and Oculis company to honor the late Professor Ramin Tadayoni and support promising retinal research. This year,…
Q&A: Daniela Bacherini discusses using ultra widefield OCT to evaluate peripheral retinal degenerations | Ophthalmology Times
Photo of Daniela Bacherini at the 2025 EURETINA meeting Daniela Bacherini, MD, PhD, FEBO, from the University of Florence presented at the EURETINA 2025 meeting, focusing on ultra widefield peripheral OCT imaging of retinal degenerations. She explored how this advanced…
Looking ahead: Ophthalmologists envision a world without the toughest diseases | Ophthalmology Times
As Ophthalmology Times celebrates its 50th anniversary, we took the opportunity to ask a thought-provoking question to some of the field’s leading experts: “In a perfect world, if you could cure one eye disease or condition with the snap of…
Q&A: Boris Stanzel on the use of methotrexate in PVR cases | Ophthalmology Times
Photo of Boris Stanzel, MD, at the 2025 EURETINA meeting Professor Boris Stanzel, MD, presented research on methotrexate’s use in PVR retinal detachment surgery at the 2025 EURETINA congress, which was held in Paris, France. The study of 20 patients…
Increased complications in cataract surgery during the COVID-19 pandemic | Ophthalmology Times
(Image credit: AdobeStock/phonlamaiphoto) Canadian researchers recently reported significant increases in complications during cataract surgeries performed during the COVID-19 pandemic compared with the pre-pandemic period.1 First author Nathan Lee-Wing, BS, and MD candidate at the Max Rady College of Medicine, University…